Intestinal inflammation and pain management.

Area of Science:

• Neurogastroenterology
• Immunology
• Pain Medicine

Background:

• Intestinal inflammation triggers pain mediators that activate sensory neurons.
• Colitogenic CD4(+) T lymphocytes produce endogenous opioids.
• Opioid receptors on sensory nerves may be targeted by these endogenous opioids.

Purpose of the Study:

• To review immune-mediated regulation of visceral inflammatory pain.
• To discuss current pain treatments for inflammatory bowel diseases (IBD).
• To explore novel opioid therapeutics for IBD pain with reduced side effects.

Main Methods:

• Literature review on immune mediators, sensory neurons, and opioids in IBD.
• Analysis of current therapeutic strategies for inflammatory visceral pain.
• Examination of preclinical and clinical data on opioid-based pain management.

Main Results:

• Inflammatory mediators directly activate colon sensory neurons, causing pain.
• Endogenous opioids from T lymphocytes may counteract inflammatory pain locally.
• Current IBD pain treatments have limitations, necessitating new approaches.

Conclusions:

• Immune cells play a dual role in regulating inflammatory pain.
• Targeting peripheral opioid pathways offers potential for effective IBD pain relief.
• Future therapies could leverage endogenous opioid systems to manage visceral pain while minimizing central side effects.